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Abstract 
The complexity of the clinical, biochemical, hystochemical and immunologic aspects of the intervertebral disk, along with its 
molecular biology, justifies the object of our study on the extracellular matrix modifications in lumbar disk hernias and their impact on 
patient quality of life. 
  Material and method: the research lot was composed of 50 patients, aged between 18 and 73, who have undergone 
lumbar disk hernia surgery. MMP-9 (metalloproteinase-9) and TIMP-1 (tissue inhibitor of matrix metalloprotease 1) have been dosed 
in order to study the modifications on extracellular disk matrix, and quality of life assessment was carried out both in pre-operatory 
and post-operatory periods. 
  Conclusions: patients may prevent the appearance of degenerative processes of the intervertebral disk with care and 
responsibility by controlling their weight, avoiding intense physical activities and ceasing to smoke. 
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Introduction 
Back pain is a major cause of discomfort and 
invalidity. This being said, the current treatment strategies 
are primarily focused on the improvement of symptoms 
and have different rates of success. For the future, and for 
the treatments to become pro-active, they have to turn 
towards cellular pathology. Intervertebral disk 
degeneration (IDD) has been linked to a large percentage 
of patients with lumbago, so inhibitory actions on the 
processes that contribute to IDD and the regeneration of 
the intervertebral disk matrix are a new current in 
research. Therapies aiming to inhibit cytokines like IL-1, 
that have a high level during IDD, have been investigated 
as possible treatments [1-5]. 
The degeneration of the disk is present during 
the natural process of aging, but there have been notes 
on accelerated degeneration processes in a series of 
young patients, underlining the pluri-factorial 
characteristic of this process. IDD is influenced by 
mechanical pressures, genetic inheritance and bio-cellular 
modifications [6-8]. 
Chondrocyte-like cells of the nucleus pulpous 
are responsible for the production of growth factors such 
as bone morphogenetic protein (BMP), transformal growth 
factor (TGF), insulin-like growth factor (IGF) and cytokines 
such as IL-1, IL-6 and tumor necrosis factor (TNF) [8]. 
Growth factors are implicated in the regulating of the 
intervertebral cellular matrix by stimulating the production 
of matrix proteins. In contrast, cytokines are inhibitors of 
matrix synthesis and stimulate the production of 
degrading enzymes like MMPs that brake the extracellular 
matrix of the intervertebral disk [6,9-12]. Chondrocyte-like 
cells are implicated in matrix synthesis, but they also 
produce enzymes implicated in the intervertebral 
degeneration process. Chondrocyte-like cells have also 
been identified in anomalies of the homeostasis process 
of the nucleus pulpous. 
The increase in the level of MMP is a 
characteristic of ODD, especially considering MMP-7, 9 
and 13, which mediate the degrading of matrix collagen 
type II [13-15]. MMP enzymes are produced in a latent 
form and impose this, in order to permit their proteolysis 
activation. Furthermore, the tissue inhibitor of the matrix 
metalloprotease (TIMP), which is found in four active 
forms – TIMP 1, 2, 3 and 4 blocks the activity of MMP. Journal of Medicine and Life Volume 4, Issue 3, July‐September 2011 
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Types 1 and 2 are the most important MMP inhibitors. 
MMPs like MMP-7 have been found to be resistant to 
TIMP 1 and 2, so they have been noted as key enzymes 
in the pathogenesis of IDD [16-19]. 
The composition of the matrix and the activity of 
the intervertebral disk are integrated parts of its 
functionality. IDD leads to loss of disk matrix material, loss 
of chondrocyte-like cells of the nucleus pulpous – which 
leads to weaknesses in the structural integrity, hydration 
modifications, decrease of mechanical capacity, 
angiogenesis and innervations modifications. These 
biological changes resulting in IDD, associated with the 
decrease of disk height, produce pain and, implicitly, alter 
the quality of the patient’s life [15,20,21]. 
Material and methods 
We have made a longitudinal, analytical, cohort 
study with an ambispective characteristic through which 
we can underline the histo-bio-chemical aspects of IDD 
pathology, correlated with the clinical aspects, risk factors, 
pre-surgery investigations and patient quality of life before 
and after the surgical intervention. The target population 
of this paper is represented by patients who had surgery 
for disk herniation during 01.01.2006 and 30.06.2009, in 
the neurosurgery clinic of “Regina Maria” Military 
Emergency Hospital in Brasov. We have studied the 
impact of the IDD process (modifications in the 
extracellular matrix) on the pre and post-surgery patient’s 
quality of life, alteration of health parameters (pain, 
mobility, usual activities, depression and self-care) on 50 
patients that were eligible for prevailing intervertebral disk 
fragments. 
Lumbar disk hernia diagnosis was made on 
anamnesis, neurological exam and neuro-imagistic 
imaging. For anamnesis, the patients were inquired 
according to the hospital chart and the Euro Quality of Life 
5D (EQ-5D). This survey is a standardized instrument for 
the evaluation of quality of life. It consists of a self-
assessment scale applied on large-scale in different 
clinical and treatment situation aiming to determine the 
quality of life according to 5 basic criteria – mobility, self-
care, usual activities, pain/discomfort, and 
unease/depression. The scale has 2 parts. In the first 
part, each criterion has 3 expression grades. The patient 
checks the grade that corresponds to his state. The 
establishment of the quotient is made by using the EQ-5D 
index. The 2nd part represents an analogical-visual scale 
with a length of 20 centimeters, graded 0 to 100 where 0 
represents the worst imaginable state of health and 100 
the best. The 2nd part scale is also known as the 
“thermometer of health-state”. Appreciating to what 
degree the quality of life was affected, was made using 
both instruments. The evaluation was made both pre-
surgery and 3 months post-surgery. 
Disk materials were acquired during the surgical 
act and were fixed in parfine. The histo-pathologic study 
on the 50 selected patients was made by using usual 
coloration (Hematoxiline-Eosin) and special colorations 
(PAS, Giemsa and Van Gieson). For emphasizing on 
extracellular matrix modifications, we have studied: 
-MMP-9 (metalloproteinase-9, gelatinase B or 
collagenase IV with a molecular mass of 92 kDa), a 
proteolytic enzyme implicated in the degrading 
conjunctive tissue. MMPs have a common path of 
activation, conservation of the amino acid sequence at the 
active link site and are inhibited by TIMPs. MMPs play an 
important role in angiogenesis control and in tumor cell 
invasion (and are used as predictive factors for this);  
-TIMP-1, that plays an important role in the 
control of MMPs activity. TIMPs constitute a family of at 
least 3 types of proteins of which TIMP-1 and TIMP-2 are 
shown in a large variety of tissue types. TIMP-1 and 
TIMP-2 are inhibitors (in variable proportions) of all types 
of active MMPs. They bind with proMMP-9 and proMMP-2 
and form stable complexes that promote the activation of 
pro-enzymes.  
Results 
For MMP-9 we have observed positive results of 
different intensities at extracellular matrix level in 34 
subjects (68%), in 16 cases (32%) the results were 
negative. (Table 1) 
 
                                     Table 1. Results for MMP-9 
MMP-9 Reaction  n   Percent     
Negative 16  32.0%   
Positive for chondrocyte like   4  8.0%   
Positive for chondrocyte  like and matrix   11  22.0%   
Positive for chondrocyte like and weak for matrix  2  4.0%   
Positive for matrix   11  22.0%   
Weak for matrix and chondrocyte like   6  12.0%   
Total   50  100.0%   
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The results of the research for TIMP-1, in the 
study, shows a positive reaction in all subjects, but of 
different intensity at the level of the cellular matrix. (Fig. 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The analysis of the data shows that the 
modification of the extracellular matrix of the disk does not 
influence the intensity of the pain in disk hernia. There is 
no association between the hyper-algic form of hernia and 
the histo-pathological modifications of the MMP-9 positive 
type (95% confidence level χ2=0,14) 
The evaluation of the health thermometry in 
post-surgery time shows a lack of epidemiologic 
association between the extracellular modification, and an 
unsatisfactory improvement in the quality of life, from the 
point of view of health thermometry. However, for the 
clinician, this is important: only 70.5% of the MMP-9 
positive subjects have reached a score over 70 post-
surgery, in comparison with 81.25% of the MMP-9 
negative subjects. The risk of those with positive MMP-9 
histo-pathologic results, not very satisfying in improving 
their quality of life is 1.75 higher than in those without 
extracellular matrix modifications. [χ2=0,64; RR=1,57 
(0,5<RR<4,94)] 
Although there is no association between the 
hyper-algic form of hernia and histo-pathological 
modification of the MMP-9 positive type, following a more 
profound analysis of many health state parameters, our 
study shows that the average EQ-5D pre-surgery score of 
the MMP-9 positive subjects is 0.4969, in comparison to 
0.5623 for the MMP-9 negative ones (χ2=9), therefore, we 
can establish that the modification in the extracellular disk 
matrix, significantly affects the patient’s pre-surgery 
quality of life, both statistically and clinically (Table 2). 
 
 
       Table 2. Frequency of MMP-9 reactions and average EQ – 5D 
MMP 9           n                    Total                  Average EQ-5D 
negative   16  8.9972  0.5623 
pos chondrocyte  like   4  2.3119  0.5780 
pos chondrocyte like and matrix   11  4.8445  0.4404 
pos chondrocyte like and weak matrix  2  1.1583  0.5791 
pos matrix   11  5.9869  0.5443 
weak pos matrix and chondrocyte like  46  2.5939  0.4323 
 
 
The risk for depression on those with MMP-9 
positive is 1.58 times higher than those with negative 
results, with statistical significance [χ2=6,49. 
(1<RR<2,56).RA=0,31]; 88,2% of the patients with 
positive MMP-9 have related episodes of depression in 
pre-operatory stage versus 56.2% of those without 
extracellular disk matrix modifications. 
The risk of not improving their state of unease or 
depression after 3 months of the surgery on those with 
positive MMP-9, is statistically significant, higher than 
those with negative MMP-9 results (χ2=5,16, RA=0,26). 
Clinically, we observed that the modification of the 
extracellular disk matrix has a negative impact on the 
improvement of the post-surgery psychical state, only 
73,5 of those with positive MMP-9 have declared the lack 
of pre-operatory depression, in comparison with the 100% 
MMP-9 negative subjects. 
Our study shows a lack of correlation between 
smoking and the modification of extracellular disk matrix. 
The risk of presenting MMP-9 positive results on smokers 
is 1.4 times higher than in non-smokers [RR= 1,4 
(1<RR<1,96), for a 95%CI χ2=2,6, , RA=0,23]. The 
prevalence of extracellular disk matrix modification in 
smokers is higher than in non-smokers (85,71% versus 
61,11%) 
The evaluation of obesity shows a lack of 
epidemiological association between excess weight and 
extracellular modification of the intervertebral disk. The 
risk to present MMP-9 positive results in obese or over-
weight persons is 1.12 times higher than in normal 
weighted persons. The effect, although of no statistical 
importance, has a high clinical impact [RR= 1,12 
(0,76<RR<1,66) for a CI of 95%, χ2=0,34, , RA=0,07]. The 
prevalence of extracellular disk matrix modification in 
Fig. 1 Intervertebral disk TIMP-1 positive in the extracellular 
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those with pathological body mass index is higher than in 
normally-weighted persons (71,4% versus 63,63%). 
Our studies show a lack of association between 
the sedentary way of life and extracellular modification of 
the intervertebral disk. The risk to present MMP-9 positive 
results in sedentary subjects by nature of occupation and 
way of life is 1.14 higher than in those who have an 
activity corresponding to a good physical shape. [RR= 
1,14 (0,71<RR<1,84) For a CI of 95%, χ2=1,14, RA=0,08]. 
The studied effect of the obtained differences, although of 
no statistical importance, has a major clinical importance. 
The prevalence of extracellular disk modifications in 
sedentary subjects is higher than in those with a healthy 
lifestyle (70,2% versus 61,5%). 
The analysis of our data shows a lack of 
association between the effort risk factor and the process 
of extracellular disk matrix modification. The risk to 
present positive MMP-9 results in those who overwork 
their back muscles is 1.11 higher than in those who do no 
cross the boundaries of maximal biomechanical stress of 
back muscles [RR= 1,11 (0,76<RR<1,63) for a CI of 95%, 
χ2=0,34, RA=0,07]. The prevalence of extracellular disk 
modifications in those who overwork the back from a 
biomechanical point of view is higher than in those without 
excessive efforts (70,2% versus 61,5%).     
The risk attributed to the relative risk 
characterizes both the aggressiveness of the risk factor 
and the frequency of the mentioned affection, so that it 
serves for the identifying of those issues that can be 
addressed and solved with maximum efficiency, and an 
optimal use of available resources. By eliminating 
smoking, we would reduce the extracellular matrix 
modifications by 23%. Having an adequate control of the 
weight, we would eliminate 7% of extracellular matrix 
modifications. Doing therapy and exercise aiming to 
harden the abdominal muscles, as well as the para-
vertebral muscles, would eliminate 8% of these processes 
while ceasing excessive efforts would eliminate 7%. 
(Graph 1)  
 
 
Graph 1. Risk that may be attributed to the conduct, that can be avoided and influence the extracellular matrix modification in IDD   
 
Discussions 
  The decrease in the number of notochord cells of 
the nucleus pulpous is associated with senescence and 
IDD (increased collagen synthesis, decreased secretion 
of proteoglicans and decreased water content). The 
reducing of the number of notochord cells after birth may 
be explained by their death and replacement with 
chondrocytes or chondrocytary differentiation [14]. 
Biochemical studies made on degenerated disks 
have shown increased catabolic enzyme levels and MMP, 
suggesting their role in degenerative processes. Gene 
therapy with anabolic factors for degenerative 
modifications of the intervertebral disk leads to increased 
proteoglican synthesis (predominantly aggrecan) and type 
II collagen. 
Proteoglicans are synthesized by notochord cells 
from the nucleus pulpous. In degenerative processes, 
there is a modification in the synthesis of matrix 
molecules with increased synthesis of collagen types I 
and III and the decreased production of proteoglicans. 
Using TIMP-1 as an MMP inhibitor in gene therapy may 
become a complementary method for solving the Journal of Medicine and Life Volume 4, Issue 3, July‐September 2011 
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degenerative process at disk level. In the catabolic 
process of IDD, MMP levels increase and TIMP levels 
decreased under the control of growth factors and 
cytokines (TNF α and IL-1). Studies made at disk level 
have emphasized the rise in MMP-1, -9 and -13. The 
expression of TIMP-1 and -2 was increased in 
degenerated disks, while TIMP-3 expression was not 
significantly high in the degeneration process. These 
results suggest that high expression of MMP is countered 
by the high expression of TIMP [19]. 
In this study, we have concluded that high MMP-
9 expression is sometimes correlated with high TIMP-1 
expression. 
  Another aim of our research was to determine 
the impact of risk factors on the cellular biology of the 
degenerated intervertebral disk. In disk hernia we have 
risk factors that cannot be avoided, such as aging, make 
gender, a history of lumbar trauma or surgery. The aging 
process of inferior lumbar intervertebral disks, as well as 
frequent disk or spinal muscle injury rise the 
predisposition for back pain, a process which debuts in 
adulthood and is frequently associated with depression 
and anxiety as a current unspecific method for coping with 
the disease state. Psychical dysfunctions per-se, as well 
as the psychical coloring of disk hernias, must be 
correctly assessed and inserted in the therapeutic 
conclusion [22]. 
  Another category of factors is that made out of 
avoidable ones: work or other activities that rise the risk of 
disk hernia – like sitting for a long period of time, lifting 
heavy objects, frequent twists or bends, hard physical 
exercise, repetitive movements or constant vibrations, 
such as driving a car, incorrect movements and exercises, 
high tension in the back muscles, hard exercises after a 
period of inactivity, smoking or obesity. Nicotine and other 
toxins may deteriorate the capacity of the intervertebral 
disks to absorb nutrients from the blood, raising the 
possibility of degeneration or destruction, and the 
increase in body weight (especially abdominal weight) 
add to a high workload for the lumbar disks [23]. 
Some patients may prevent the apparition of 
degenerative processes of the intervertebral disk, or the 
aggravation of symptoms, if they are caring and 
responsible while maintaining their weight under control, 
adopting a correct posture, avoiding intense physical 
activities, ceasing to smoke and avoiding aggravating 
factors (damp, cold) [23]. 
Conclusions 
1.  In this study, we have concluded that the 
presence of extracellular matrix modifications in 
lumbar disks and the increased expression of 
MMP-9 is correlated with the increase in TIMP-1 
expression. (MMP-9 positive in 68% of subjects 
and 100% TIMP-1 positive). The high incidence 
of MMP positive results suggests their role in the 
degenerative process. 
2.  The modification of extracellular disk matrix has 
a significant negative statistic a and clinical 
impact on the improvement of post-surgery 
psychical state; this process being associated in 
epidemiology with a high recurrence of pre-
surgery depression and a poorer pre-surgery 
quality of life (average EQ-5D pre-operatory in 
MMP-9 positive is 0,4969 versus 0,5623 in MMP-
9 negative subjects. In chronic disk hernia, in 
moderate but repetitive crisis, the occurrence of 
a psychical reaction is justified. Presenting all 
these psychological coping mechanism in impact 
with an organic illness emphasizes a classical 
issue: the results of the surgical treatment of 
lumbar disk hernia are highly influenced by the 
psychopathologic element. 
3.  Smoking, excess weight, sedentary way of life 
and effort, raise the reoccurrence of extracellular 
disk matrix modification processes. By 
eliminating smoking with an adequate control of 
weight, by exercises aiming to strengthen the 
abdominal and the para-vertebral muscles, and 
by eliminating excessive efforts, we would 
reduce the extracellular disk matrix modification 
processes in the degenerative disk by 7% to 
23%. 
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